# Correction to: An integrated approach of network pharmacology, molecular docking, and experimental verification uncovers kaempferol as the effective modulator of HSD17B1 for treatment of endometrial cancer

**Authors:** Guan‑Yu Ruan, Li‑Xiang Ye, Jian‑Song Lin, Hong‑Yu Lin, Li‑Rui Yu, Cheng‑Yan Wang, Xiao‑Dan Mao, Shui-Hua Zhang, Peng‑Ming Sun

PMC · DOI: 10.1186/s12967-026-07698-x · 2026-02-13

## Full-text entities

- **Genes:** HSD17B1 (hydroxysteroid 17-beta dehydrogenase 1) [NCBI Gene 3292] {aka 17-beta-HSD, 20-alpha-HSD, E2DH, EDH17B2, EDHB17, HSD17}
- **Diseases:** endometrial cancer (MESH:D016889)
- **Chemicals:** kaempferol (MESH:C006552)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12903716/full.md

---
Source: https://tomesphere.com/paper/PMC12903716